A leading Biopharmaceutical company in China engaging in R&D, manufacturing and marketing of gene engineering and biochemical drugs including: Filgrastim, Oprelvekin (Interleukin-11), Enoxaparin sodium, Palonosetron and BMP-2 (Recombinant Human Bone Morphogenetic Protein-2). Drug pipeline mainly includes Liraglutide, Fulvestrant, Fosaprepitant, pegfilgrastim, long lasting EPO and other high value biosimilars and long lasting formulations.
View Top Employees from Hangzhou Jiuyuan Gene Engineering Co., Ltd.Website | http://www.china-gene.com |
Revenue | $5.2 million |
Employees | 21 (21 on RocketReach) |
Founded | 1993 |
Phone | +86 571 8687 9123 |
Technologies |
JavaScript,
HTML,
Google Analytics
+4 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 17 Million |
Keywords | 岗位设置论证意见 |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Hangzhou Jiuyuan Gene Engineering Co., Ltd. employee's phone or email?
The Hangzhou Jiuyuan Gene Engineering Co., Ltd. annual revenue was $5.2 million in 2024.
Li Zhou is the Director, Overseas Marketing of Hangzhou Jiuyuan Gene Engineering Co., Ltd..
21 people are employed at Hangzhou Jiuyuan Gene Engineering Co., Ltd..
The NAICS codes for Hangzhou Jiuyuan Gene Engineering Co., Ltd. are [32541, 32, 325, 3254].
The SIC codes for Hangzhou Jiuyuan Gene Engineering Co., Ltd. are [28, 283].